1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow NALCN Channelopathy: new trials by email Literature Review of NALCN Channelopathy trials Research Report on NALCN Channelopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aprepitant for the Treatment of CLIFAHDD Aprepitant Powder for Oral Suspension - CLIFAHDD, Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 5 | 2026-10-31 | 2026-10-05 |
Ataxia (1) · Channelopathies (1) · Disease (1) · Facies (1) · Learning Disabilities (1) · Muscle Hypotonia (1) · Neurodevelopmental Disorders (1)
Communication Disorders (1) · Disease Attributes (1) · Dyskinesias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Aprepitant (1) · Suspensions (1)
The University of Texas Health Science Center at San Antonio (1)
United States (1)